Patents (1436 Stem Cell Patents)

Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction

Patent Number: 6607720

Date of First Priority Issue: Tuesday September 5th, 2000
Date Issued: Tuesday August 19th, 2003
Assignee: Unknown Assignee(s)
Inventors: Xiao, Yong-Fu (Wayland, MA); Morgan, James P. (Newton Centre, MA)

From Class: Type
Comments: No comments

This patent covers the use of embryonic stem cells as a source of stem cells for myocardial regeneration. Specifically, this patent covers genetically manipulated cells that are useful for these purposes.

View this patent on the USPTO website.

Added to StemCellPatents.com on Monday October 16th, 2006

Social & Bookmarking:Digg 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' Add 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' to del.icio.us Add 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' to Technorati Stumble 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' Add 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' to Furl Add 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' to Reddit Add 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' to Blinklist Add 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' to Ma.gnolia Share 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' on Facebook Add 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' to Google Add 'Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction' to Yahoo Web 

Add Comment

You must be signed-in to add your comments.

Sign-in now or Join the StemCellPatents.com Community for free.



Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent